Vinorelbine, ifosfamide and cisplatin in advanced non-small cell lung cancer

Acta Oncologica

Volumn 38, Issue 5, 1999, Pages 619-622

  Tan, Eng Huat ^a   Ang, Peng Tiam ^b   Wee, Joseph ^b   Fong, Kam Weng ^b   Leong, Swan Swan ^b   Khoo, Kei Siong ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DEXAMETHASONE; IFOSFAMIDE; MESNA; NAVELBINE; SEROTONIN 3 ANTAGONIST;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE;

EID: 0032816411     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699431212     Document Type: Article

References (18)

1. 1. Ruckdeschel JC, Finkelstein DM, Mason BA, Creech RH. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575 generation V-a randomized comparison of four cisplatin-containing regimens. J Clin Oncol 1985; 3: 72-9.
2. 2. Ruckdcschel JC, Finkelstein DM, Ettinger DS, et al. A randomized trial of the four most active regimens for metastatic non-small cell lung cancer. J Clin Oncol 1986; 4: 14-22.
3. 3. Einhorn LH, Loehrer PJ, Williams SD, et al. Randomized prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin-C in advanced non-small cell lung cancer. J Clin Oncol 1986; 7: 1037-43.
4. 4. Bonomi PD, Finkelstein DM, Ruckdeschel JC, et al. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small cell lung cancer: a study of the Eastern Cooperative Oncology Group. J Clin Oncol 1989; 7: 1602-13.
5. 5. Rosell R, Abad-Esteve A, Moreno I, et al. A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin-C or ifosfamide in patients with advanced non-small cell lung cancer. Cancer 1990; 65: 1692-9.
6. 6. Feigal EG, Christian M, Cheson B, Grever M, Friedman MA. New chemotherapeutic agents in non-small cell lung cancer. Semin Oncol 1993; 20: 185-201.
7. 7. Depierre A, Lemarie E, Dabouis G, et al. A phase II study of navelbine in the treatment of non-small cell lung cancer. Am J Clin Oncol 1991; 14: 115-9.
8. 8. Fernandez O, Bruno J, Mickiewicz E, et al. Randomized comparison of navelbine (NVB) with cisplatin (CDDP) versus navelbine alone in patients with inoperable non-small cell lung cancer (NSCLC). Proceedings of the 15th International Cancer Congress. J Cancer Res Clin Oncol V 1990; 116 (Suppl): [00-00??].
9. 9. Le Chevalier T, Pujol JL, Doullard JY, et al. A three-arm trial of vinorelbine (navelbine), plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis. Semin Oncol 1994; 20 (Suppl 10); 28-34.
10. 10. Grilli R, Oxman AD, Julian JA. Chemotherapy for advanced non-small cell lung cancer: How much benefit is enough? J Clin Oncol 1993; 11: 1866-72.
11. 11. Souquet PJ, Chauvin F, Boissel JP, et al. Polychemotherapy in advanced non-small cell lung cancer: a meta-analysis. Lancet 1993; 342: 19-21.
12. 12. Non-small Cell Lung Cancer Trialists' Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated individual patient data from 52 randomised clinical trials. Br Med J 1995; 311: 889-909.
13. 13. Marino P, Pampallona S, Preatoni A, Cantoni A, Invernizzi F. Chemotherapy vs supportive care in advanced non-small cell lung cancer. Results of a meta-analysis of the literature. Chest 1994; 106: 861-5.
14. 14. Langer CJ, Leighton JC, Comis RL, et al. Paclitaxel and carboplatin in combination in the treatment of advanced non-small cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol 1995; 13: 1860-70.
15. 15. Baldini E, Tibaldi C, Chella A, et al. Combination chemotherapy with vinorelbine, ifosfamide and cisplatin: a phase II study in stage IIIB-IV non-small cell lung cancer. Semin Oncol 1994; 21 (Suppl 4): 12-5.
16. 16. Abratt RP, Bezwoda WR, Goedhals L, Hacking DJ. Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small cell lung cancer. J Clin Oncol 1997; 15: 744-9.
17. 17. Crino L, Scagliotti G, Marangolo M, et al. Cisplatin-gemcitabine combination in advanced non-small cell lung cancer: a phase II study. J Clin Oncol 1997; 15: 297-303.
18. 18. Sugiura S, Ando Y, Minami H, et al. Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res 1997; 3: 47-50.